Skip to Main content Skip to Navigation
Journal articles

Differentiating iron-loading anemias using a newly developed and analytically validated ELISA for human serum erythroferrone

Abstract : Erythroferrone (ERFE), the erythroid regulator of iron metabolism, inhibits hepcidin to increase iron availability for erythropoiesis. ERFE plays a pathological role during ineffective erythropoiesis as occurs in X-linked sideroblastic anemia (XLSA) and β-thalassemia. Its measurement might serve as an indicator of severity for these diseases. However, for reliable quantification of ERFE analytical characterization is indispensable to determine the assay’s limitations and define proper methodology. We developed a sandwich ELISA for human serum ERFE using polyclonal antibodies and report its extensive analytical validation. This new assay showed, for the first time, the differentiation of XLSA and β-thalassemia major patients from healthy controls (p = 0.03) and from each other (p<0.01), showing the assay provides biological plausible results. Despite poor dilution linearity, parallelism and recovery in patient serum matrix, which indicated presence of a matrix effect and/or different immunoreactivity of the antibodies to the recombinant standard and the endogenous analyte, our assay correlated well with two other existing ERFE ELISAs (both R 2 = 0.83). Nevertheless, employment of one optimal dilution of all serum samples is warranted to obtain reliable results. When adequately performed, the assay can be used to further unravel the human erythropoiesis-hepcidin-iron axis in various disorders and assess the added diagnostic value of ERFE.
Complete list of metadata
Contributor : Nathalie Seguin <>
Submitted on : Wednesday, August 18, 2021 - 4:10:13 PM
Last modification on : Friday, August 20, 2021 - 9:13:50 AM


Publisher files allowed on an open archive


Distributed under a Creative Commons Attribution 4.0 International License




Laura Diepeveen, Rian Roelofs, Nicolai Grebenchtchikov, Rachel van Swelm, Leon Kautz, et al.. Differentiating iron-loading anemias using a newly developed and analytically validated ELISA for human serum erythroferrone. PLoS ONE, Public Library of Science, 2021, 16 (7), 14 p. ⟨10.1371/journal.pone.0254851⟩. ⟨hal-03321984⟩



Record views


Files downloads